← All decks

Dermatology

Cutaneous T Cell Lymphoma

Built from Dermatology, 5th Edition

The first 25 slides of Cutaneous T Cell Lymphoma
The first 25 slides, exactly as they appear. The full deck has 135 content slides.

What’s inside

11 sections · 135 slides

  1. 01

    Overview

    • What this topic covers
    • Cutaneous T cell lymphoma (CTCL): the big picture

    2 slides

  2. 02

    What Cutaneous T Cell Lymphoma Is

    A short history of the concept, and how it came to be classified

    • A skin-based cancer, diagnosed at the bedside
    • A brief history of mycosis fungoides
    • How the CTCL concept was born
    • Why "primary cutaneous" lymphomas needed their own rules
    • Three main categories of CTCL
    • From EORTC to the 2018 WHO-EORTC classification
    • Classification algorithm for cutaneous T cell lymphoma
    • WHO-EORTC classification: frequency and 5-year survival by CTCL type

    8 slides

  3. 03

    Diagnosis, Classification, and Staging

    How a biopsy, an antibody panel, and the clinical picture combine into one diagnosis

    • Step one: is this a lymphoma at all?
    • Immunophenotyping: reading the antibody panel
    • T cell receptor (TCR) gene rearrangement testing
    • High-throughput TCR sequencing (HTS-TCR)
    • One biopsy picture, several possible diagnoses
    • Differential diagnosis by histologic pattern
    • Differential diagnosis of common histologic patterns in cutaneous T cell lymphoma (CTCL)
    • Differential diagnosis of common histologic patterns in cutaneous T cell lymphoma (CTCL) (continued)
    • Differential diagnosis of common histologic patterns in cutaneous T cell lymphoma (CTCL) (continued)
    • Differential diagnosis of common histologic patterns in cutaneous T cell lymphoma (CTCL) (continued)
    • A practical three-step approach to classification
    • Staging: how much work-up does each type need?

    12 slides

  4. 04

    Mycosis Fungoides

    The most common CTCL - classic patch, plaque, and tumor stage disease

    • Mycosis fungoides (MF): definition and how common it is
    • Who gets mycosis fungoides
    • Genetic changes behind mycosis fungoides
    • Staphylococcus aureus as a tumor accelerator
    • Environmental exposure: an unproven trigger
    • The immune system's own fight against the tumor
    • When the tumor's immune balance tips the wrong way
    • The classic course: patch, then plaque, then tumor
    • Limited patch stage disease (stage IA)
    • Hypopigmented mycosis fungoides
    • Generalized patch/plaque stage disease (stage IB)
    • Tumor stage mycosis fungoides
    • Mycosis fungoides, additional stage IB presentation
    • Hypopigmented mycosis fungoides, additional example
    • Mycosis fungoides in an adult with widespread hypopigmentation
    • Hypopigmented mycosis fungoides in a child
    • Large cell transformation
    • Erythrodermic mycosis fungoides with large cell transformation
    • Mycosis fungoides with large cell transformation, before and after transplant
    • Immunophenotype of the tumor cells
    • What else can look like mycosis fungoides
    • Staging mycosis fungoides: the TNMB system
    • TNMB classification of mycosis fungoides and Sézary syndrome
    • TNMB classification of mycosis fungoides and Sézary syndrome (continued)
    • TNM-based clinical stage groups for mycosis fungoides and Sezary syndrome
    • What the staging work-up actually involves
    • 96%
    • Treatment principle: match therapy to stage
    • Escalation ladder for mycosis fungoides treatment
    • Topical corticosteroids and topical chemotherapy
    • Radiotherapy: total skin electron beam (TSEB)
    • Local radiotherapy for a single lesion
    • Phototherapy: PUVA and narrowband UVB
    • Systemic biologic therapies: interferon and retinoids
    • Targeted systemic agents
    • Systemic chemotherapy and stem cell transplant
    • Treatment of mycosis fungoides
    • Treatment of mycosis fungoides (continued)
    • Treatment of mycosis fungoides (continued)

    39 slides

  5. 05

    Variants of Mycosis Fungoides

    Folliculotropic MF, pagetoid reticulosis, and granulomatous slack skin

    • Folliculotropic mycosis fungoides
    • Infiltrated eyebrow plaque with hair loss
    • Other clinical patterns of folliculotropic MF
    • Acneiform folliculotropic mycosis fungoides of the face
    • Pathology and treatment of folliculotropic MF
    • Pagetoid reticulosis
    • Solitary plaque of pagetoid reticulosis
    • Granulomatous slack skin
    • Pendulous folds of lax skin in the groin

    9 slides

  6. 06

    Sezary Syndrome

    Erythroderma, blood involvement, and a T cell clone shared between skin and blood

    • Sezary syndrome (SS): definition
    • How common Sezary syndrome is
    • Erythroderma of Sezary syndrome
    • Pathology of Sezary syndrome
    • Sezary cell ultrastructure
    • What drives Sezary syndrome
    • Telling Sezary syndrome apart from other causes of erythroderma
    • Treatment: extracorporeal photopheresis and systemic options
    • Mogamulizumab and its skin side effect

    9 slides

  7. 07

    Adult T Cell Leukemia/Lymphoma

    A T cell cancer caused by a specific virus, HTLV-1

    • Adult T cell leukemia/lymphoma (ATLL)
    • Global distribution of HTLV-1 infection
    • Skin lesions of adult T cell leukemia/lymphoma
    • Pathology, diagnosis, and treatment of ATLL

    4 slides

  8. 08

    Primary Cutaneous CD30-Positive Lymphoproliferative Disorders

    Lymphomatoid papulosis and cutaneous anaplastic large cell lymphoma - one spectrum, two clinical faces

    • A spectrum, not two separate diseases
    • Diagnosis and treatment algorithm for CD30-positive lymphoproliferations
    • Primary cutaneous anaplastic large cell lymphoma (C-ALCL)
    • Solitary tumor of primary cutaneous anaplastic large cell lymphoma
    • Immunophenotype and genetics of C-ALCL
    • Treating C-ALCL
    • Lymphomatoid papulosis (LyP): definition
    • How common LyP is, and who gets it
    • Papulonecrotic lesions of lymphomatoid papulosis
    • Is LyP linked to other lymphomas?
    • LyP's variable biopsy picture
    • Lymphomatoid papulosis (LyP) – histologic subtypes and their differential diagnoses
    • Lymphomatoid papulosis (LyP) – histologic subtypes and their differential diagnoses (continued)
    • Lymphomatoid papulosis, type D
    • Agminated (clustered) lymphomatoid papulosis
    • Managing lymphomatoid papulosis

    16 slides

  9. 09

    Subcutaneous Panniculitis-Like T Cell Lymphoma

    A cytotoxic T cell lymphoma of fat tissue, sometimes complicated by macrophage overactivation

    • Subcutaneous panniculitis-like T cell lymphoma (SPTCL)
    • Nodular lesions of subcutaneous panniculitis-like T cell lymphoma
    • Autoimmune disease overlap and the risk of HLH
    • Immunophenotype and a key genetic finding
    • Comparison of subcutaneous panniculitis-like T cell lymphoma (SPTCL) and primary cutaneous gamma/delta T cell lymphoma (PCGD-TCL) with subcutaneous involvement 53
    • Treating SPTCL

    6 slides

  10. 10

    Extranodal NK/T Cell Lymphoma, Nasal Type

    An aggressive, virus-associated lymphoma that often starts in the nose

    • Extranodal NK/T cell lymphoma, nasal type
    • Cutaneous involvement in extranodal NK/T cell lymphoma
    • Ulceronecrotic nasal mass in NK/T cell lymphoma
    • Extranodal NK/T cell lymphoma with active EBV infection
    • Pathology and treatment of nasal NK/T cell lymphoma
    • Hydroa vacciniforme-like lymphoproliferative disorder

    6 slides

  11. 11

    Rare Cytotoxic and Other CTCL Subtypes

    Aggressive epidermotropic CD8+ disease, acral CD8+ disease, gamma/delta lymphoma, CD4+ small/medium disease, and PTCL NOS

    • Primary cutaneous aggressive epidermotropic CD8+ cytotoxic T cell lymphoma
    • Generalized skin lesions of aggressive epidermotropic CD8+ CTCL
    • Primary cutaneous acral CD8+ T cell lymphoproliferative disorder
    • Primary cutaneous CD8+ acral T cell lymphoproliferative disorder
    • Primary cutaneous gamma/delta T cell lymphoma (PCGD-TCL)
    • Plaques and nodules of primary cutaneous gamma/delta T cell lymphoma
    • Primary cutaneous CD4+ small/medium T cell lymphoproliferative disorder
    • Primary cutaneous peripheral T cell lymphoma, NOS
    • Rapidly growing tumors of primary cutaneous peripheral T cell lymphoma, NOS
    • Cutaneous nodules in peripheral T cell lymphoma, NOS
    • Prognosis and treatment of PTCL, NOS
    • Putting it all together
    • Three ideas to take away
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Dermatology, 5th Edition (2-Volume Set)

    24 slides